UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 19, 2019
Accession Number:
0001493152-19-003319
Submission Type:
POS AM
CIK:
0001572552
Company Name:
Asterias Biotherapeutics, Inc.
File Number:
333-215154